Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Linagliptin on Intestinal Triglyceride-rich-lipoprotein Metabolism in Type 2 Diabetic Patients

NCT02280174 is registered in ClinicalTrials.gov with Ministry of Public Health, Argentina as lead sponsor.

NCT NCT02280174
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02280174 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Linagliptin on Intestinal Triglyceride-rich-lipoprotein Metabolism in Type 2 Diabetic Patients
Lead sponsor
Ministry of Public Health, Argentina
Phase
Phase 4
Overall status
Unknown status
Start date
September 30, 2014
Completion date
October 31, 2016
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes